ScandiBio
Stockholm, SE · 1 known investors
Find your way into ScandiBio
18 people in our graph share verified history with the ScandiBio team — schools, employers, funds. One of them is your warm intro.
Magnus Bergmanunlockedknows Olof Nord · together at Royal Institute of Technology (KTH) (overlapped)
×4knows the team · via Biotage
×5knows the team · via Royal Institute of Technology (KTH)
knows the team · via Affibody AB
knows the team · via SwedenBIO
ScandiBio Therapeutics is a biotechnology company developing therapeutics based on research from leading Swedish and UK academic institutions. The company was founded by researchers from KTH Royal Institute of Technology, Karolinska Institutet, Sahlgrenska Academy, and King's College London.
Founders & leadership
AM
Adil MardinogluDr
MU
Mathias UhlenProfessor
JB
Jan BorenProfessor
ON
Olof NordinCEOOlof Nord holds a doctorate in biotechnology and a master's degree in chemical engineering, and brings over 25 years of experience in life sciences, healthcare, and medtech industries across multiple executive and leadership roles, including previous founding of a biopharmaceutical company.
Investors · 1
In the news
Frequently asked questions
- What does ScandiBio do?
- ScandiBio Therapeutics is a biotechnology company developing therapeutics based on research from leading Swedish and UK academic institutions. The company was founded by researchers from KTH Royal Institute of Technology, Karolinska Institutet, Sahlgrenska Academy, and King's College London.
- Who founded ScandiBio?
- ScandiBio was founded by Adil Mardinoglu, Mathias Uhlen, Jan Boren.
- Who are ScandiBio's investors?
- ScandiBio's investors include Navigare Ventures.
- Where is ScandiBio headquartered?
- ScandiBio is headquartered in Stockholm, SE.